Triple-Hormone-Receptor Agonist Retatrutide for Obesity Weekly retatrutide injections (1 mg12 mg) resulted in weight reductions of 7.217.5% at 24 weeks and 8.724.2% at 48 weeks in subjects with overweight or obesity (without T2DM) in a phase II, double-blind, randomized, placebo-controlled [125]
It has gained popularity as a regenerative wellness and integrative veterinary medicine to treat conditions such as chronic inflammation, delayed healing, orthopedic injuries, digestive issues, and recovery support
References Paans NPM, Bot T, van Strien IA, Brouwer M, Visser BWJH
These adverse events typically occur at the time of treatment initiation or during dose escalation
Third-party HPLC-MS tested, 99% purity
Yes, body odour is a common side effect usually seen after receiving CARNISURE 1GM INJECTION